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In Nigeria, Community Pharmacists (CPs) 
and Patent and Proprietary Medicine 
Vendors (PPMVs) are the first point of care 
for many common illnesses within the 
community. Although CPs and PPMVs are 
not formally recognized as family planning 
(FP) service providers, 22% of modern 
contraceptive users report receiving their 
last method from a PPMV and 12% from a 
private pharmacy.1 PPMVs are especially 
popular for FP due to their widespread 
availability, consistent drug stocks, 
extended hours, personable interactions, 
and no separate fees for consultations.2,3 
As the Federal Ministry of Health (FMoH) 
explores expanding its task sharing policy 
to include CPs and PPMVs, evidence is 
needed on an effective regulatory system 
to support PPMVs and CPs to provide high 
quality FP services. 
 
THE INTEGRATE PROJECT 
The IntegratE Project is a four-year 
initiative (2017-2021) funded by the Bill & 
Melinda Gates Foundation and MSD for  
 
Mothers4 that seeks to increase access to 
contraceptive methods by involving the 
private sector (CPs and PPMVs) in FP 
service delivery in Lagos and Kaduna 
states. IntegratE is implemented by a 
consortium of partners led by Society for 
Family Health and includes Marie Stopes 
International Organization Nigeria, 
Planned Parenthood Federation of Nigeria, 
Population Council and PharmAccess. The 
project seeks to establish a regulatory 
system with the Pharmacists Council of 
Nigeria (PCN) to ensure that CPs and 
PPMVs provide quality FP services, comply 
with FP regulations, and report service 
statistics to the Health Management 
Information System (HMIS). 
 
To achieve this, the IntegratE Project in 
collaboration with PCN and the FMoH, is 
implementing three main activities: (1) a 
pilot 3-tiered accreditation system for 
PPMVs based on their healthcare 
qualifications; (2) a pilot hub-and-spoke 
supervisory model where CPs (the hub) 
provide support to PPMVs (spokes) to 
ensure standard drug stocking practices; 
and (3) building the capacity of CPs and 
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PPMVs to provide expanded FP services 
and report service statistics to the HMIS. 
 
Under the pilot accreditation system, 
PPMVs were provided with a standardized 
FP training to enable them to offer certain 
FP services based on their tier (Table 
above). CPs function outside of the pilot 
accreditation system but would receive 
the same training and provide the same 
services as Tier 2 PPMVs. The IntegratE 
Project is simultaneously raising 
awareness about the FP services that CPs 
and PPMVs provide. This brief focuses on 
comparing the following outcomes 
among PPMVs and CPs: knowledge of FP 
and QoC received as reported by FP 
clients served. Additional information on 
the IntegratE Project can be found at 
www.integrateeproject.org.ng.   
 
METHODS 
The IntegratE Project conducted a mixed-
methods study to assess the effect of a 
series of interventions implemented by the 
IntegratE project on PPMV and CPs’ 
capacity to provide FP. This brief builds of 
off two existing analysis and focuses on 
two important components: provider 
knowledge of FP services and QoC 
received as reported by FP clients. 
 
Provider Knowledge: Between 2019 and 
2020, 607 CPs and PPMVs from Kaduna 
and Lagos states trained by the IntegratE 
project were enrolled into the study. As 
part of the study, enrolled CPs and PPMVs 
completed a self-administered 9-month 
follow-up knowledge assessment in 2020 
Results presented in this brief are related 
to general knowledge for FP counseling 
(common to training received by all three 
provider groups) to compare results 
across Tier 1 PPMVs (n=74) Tier 2 PPMVs 
(n=213) and CPs (n=272). 
 
Quality of Care (QoC): Between June and 
November of 2019, clients were 
interviewed after receiving FP services 
from trained CPs and PPMVs. Clients who 
received FP services from CPs in Kaduna 
and Lagos states were contacted within 
approximately 10 days of receiving 
services by a data collector by phone 
about the services that they received. QoC 
scores were categorized into high, 
medium, and low and disaggregated by 
provider type: Tier 1 PPMVs (n=98) Tier 2 
PPMVs (n=305) and CPs (n=94). 
 
STUDY FINDINGS: PROVIDER 
KNOWLEDGE 
The provider knowledge assessments 
found few significant differences in FP 
knowledge among Tier 1 and Tier 2 
PPMVs and CPs at 9-months post-training. 
All Tier 1 PPMVs, Tier 2 PPMVs, and CPs 
had correct knowledge that condoms 
prevent pregnancy and HIV, and nearly all 
knew that clients should be allowed to 
handle an FP method to reassure them 
(Figure 1). In terms of differences in 
knowledge, 50% of CPs compared to 53% 
of Tier 2 PPMVs and 18% of Tier 1 PPMVs 
knew that the Copper IUD is not a 
hormonal contraceptive method (p-value < 
0.01). 95% of CPs compared to 93% of 
Tier 2 PPMVs and 81% of Tier 1 PPMVs 
knew that the selection of a contraceptive 
method is most appropriately done by a 
client seeking a contraceptive method (p-
value < 0.01). 
An analysis was run to assess differences 
in knowledge between Tier 1 and Tier 2 
PPMVs. Statistically significant differences 
were observed for correctly identifying that 
the Copper IUD is not a hormonal 
contraceptive, and that the selection of 
contraceptive method is most 
appropriately done by the client (data not 
shown). 
 












Regarding knowledge on a range of 
modern FP methods, PPMVs and CPs 
possessed similar knowledge for eight FP 
methods (Figure 2). This knowledge was 
high for nearly all methods but dropped 
slightly for standard days method and 
permanent methods. Compared to CPs 
and Tier 2 PPMVs, Tier 1 PPMVs 
demonstrated lower levels of knowledge 
of the eight modern FP methods. Lower 
levels of knowledge were most noticeable 
for permanent FP methods including tubal 
ligation (76%) and vasectomy (74%), 
standard days method (82%), IUD (86%) 
and emergency contraception (86%). 
 
Figure 1: Proportion PPMVs and CPs who had correct FP counseling knowledge at the 9-
month follow-up (n=559) 
 
** p-value < 0.01; * p-value < 0.05 
 
Figure 2: Proportion of PPMVs and CPs who correctly identified a range of modern FP 
methods at the 9-month follow-up (n=559)  
 














Condoms are the only
method that prevents
both pregnancy & HIV
Copper IUD is not a
hormonal method**
Selection of a FP
method is most
appropriately done by a
method-seeking
client**
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Figure 3: Distribution of clients’ report of quality of care received by provider visited (Tier I 
and 2 PPMVs and CPs) (n=497)** 
 
** p-value < 0.01 
 
STUDY FINDINGS: QUALITY OF 
CARE 
While QoC received by Tier 1 and Tier 2 
PPMV clients was found to be similar, 
those seen by a CPs reported receiving 
lower QoC (Figure 3). More women who 
saw a CP received low QoC (42%) 
compared to women who saw Tier 2 
PPMVs (21%) or Tier 1 PPMVs (20%, p-
value < 0.01). Only 26% of women who 
saw a CP received high QoC, compared to 
41% of who saw a Tier 2 PPMV and 37% 
of who saw a Tier 1 PPMV. 
When comparing QoC received from 
clients seen by Tier 1 and 2 PPMVs, most 
women received high or medium quality of 
care and there was no statistically 
significant difference in care received 
between the two tiers (data not shown). 
CONCLUSIONS & IMPLICATIONS 
These results suggest that FP counseling 
knowledge was good for all three provider 
types and therefore, Tier 1 PPMVs are as 
good of a source of FP counseling as Tier 
2 PPMVs and CPs. Tier 1 PPMVs’ 
knowledge of modern FP methods could 
be improved but all providers indicated 
less knowledge for methods not offered 
routinely, like permanent contraception. 
Further, FP clients reported receiving 
comparable quality of care from Tier 1 and 
Tier 2 PPMVs. Results show that clients 
received lower levels of quality of care 
from CPs, which may be due to their low 
interest in providing FP services. Further 
research should explore the reasons why 
CPs may be poorly motivated to provide 
quality FP services. Routinely collecting 
data from clients about quality of care 
received through a digital platform may 
help providers improve their services 
continuously and over time. 
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